Side effects cited as patients’ many common reason for skipping hormone-blocking therapy or interlude early Newswise — ANN ARBOR, Mich. — One-quarter of women who should take hormone-blocking therapies as partial of their breast cancer diagnosis possibly do not start or do not finish a five-year course, according to a new investigate led by University [...]
↧